Newbury Pharmaceuticals AB (publ) reported earnings results for the second quarter and six months ended February 28, 2023. For the second quarter, the company reported sales was SEK 1.5 million compared to SEK 0.302 million a year ago. Net loss was SEK 4.84 million compared to SEK 3.67 million a year ago.
For the six months, sales was SEK 1.76 million compared to SEK 0.302 million a year ago. Net loss was SEK 10.58 million compared to SEK 7.41 million a year ago.